recomLine CMV

Mikrogen recomLine CMV tests are serological, qualitative in vitro line immunoassays based on recombinantly produced antigens. The test is used as a confirmatory test of positive and inconclusive screening results. The low predictive value of a positive CMV IgM detection, due to persistent IgM or recurrent infection, makes reliable diagnosis of CMV infection particularly difficult. Using the recomLine CMV, IgG, IgM as well as the avidity of IgG antibodies can be determined. Phase-specific antigens and avidity antigens (patented by MIKROGEN on the Immuno-Line Assay) allow detection of antibodies in all phases of infection. In addition to viral load, the recomLine CMV can be used in pregnancy diagnostics as well as in preoperative diagnostics in transplant patients to detect CMV infection and to determine the time of infection.

The recomLine CMV tests provide a clear answer to the question of what effects the present infection may have on the health status of the individual patient and thus support an optimal therapy decision.